This is a table of type proper and their frequencies. Use it to search & browse the list to learn more about your study carrel.
| proper | frequency |
|---|---|
| COVID-19 | 817 |
| SARS | 612 |
| T | 581 |
| Health | 562 |
| mg | 558 |
| China | 477 |
| CoV-2 | 402 |
| C | 374 |
| HIV | 361 |
| CI | 338 |
| Hospital | 321 |
| kg | 280 |
| University | 271 |
| Background | 249 |
| Age | 248 |
| MRI | 240 |
| II | 226 |
| Disease | 220 |
| COPD | 218 |
| M | 216 |
| ABSTRACT | 213 |
| B | 212 |
| Group | 211 |
| A | 206 |
| GFR | 198 |
| PCR | 197 |
| United | 193 |
| ICU | 193 |
| National | 191 |
| UTI | 183 |
| Fig | 183 |
| UK | 181 |
| BMI | 180 |
| Canada | 179 |
| CKD | 177 |
| Study | 175 |
| VUR | 174 |
| PD | 170 |
| L | 169 |
| FC | 162 |
| IV | 160 |
| CD4 | 160 |
| US | 159 |
| Table | 157 |
| Department | 154 |
| Care | 154 |
| J | 153 |
| D | 151 |
| NS | 150 |
| IgA | 148 |
| CT | 147 |
| States | 145 |
| CD8 | 144 |
| IL-6 | 139 |
| S | 133 |
| Italy | 132 |
| NK | 130 |
| Japan | 129 |
| FSGS | 129 |
| Alzheimer | 127 |
| Research | 126 |
| Hong | 126 |
| Center | 126 |
| CMV | 126 |
| Children | 125 |
| I | 125 |
| CSSA | 124 |
| AIDS | 124 |
| Medical | 123 |
| MT | 122 |
| Europe | 122 |
| New | 121 |
| Kong | 121 |
| Spain | 120 |
| CVD | 116 |
| Netherlands | 114 |
| MS | 113 |
| USA | 112 |
| South | 110 |
| IFN | 110 |
| F | 110 |
| January | 108 |
| Sarcopenia | 108 |
| CSF | 106 |
| M. | 104 |
| Medicine | 103 |
| C. | 103 |
| Syndrome | 102 |
| CVID | 102 |
| April | 102 |
| < | 102 |
| Frailty | 101 |
| ACE2 | 101 |
| World | 100 |
| Israel | 100 |
| PICU | 99 |
| ESRD | 99 |
| Bronze | 98 |
| Germany | 98 |
| Community | 98 |
| Pediatric | 96 |
| BP | 96 |
| ARDS | 96 |
| S. | 96 |
| SCID | 95 |
| Institute | 95 |
| Africa | 95 |
| HSP | 94 |
| CRP | 94 |
| May | 93 |
| E. | 93 |
| ~ | 92 |
| OP | 92 |
| K | 92 |
| European | 91 |
| p<0.01 | 91 |
| N | 91 |
| City | 90 |
| Social | 88 |
| Index | 88 |
| EBV | 88 |
| J. | 87 |
| III | 87 |
| RNA | 86 |
| A. | 86 |
| SRNS | 85 |
| ROS | 85 |
| G | 85 |
| CRF | 85 |
| BCE | 84 |
| RSV | 84 |
| Coronavirus | 83 |
| NP | 82 |
| York | 81 |
| VA | 81 |
| TGF | 81 |
| U | 80 |
| Toronto | 79 |
| March | 79 |
| IgG | 79 |
| CNS | 79 |
| CGD | 79 |
| September | 79 |
| SPPB | 78 |
| HSCT | 78 |
| CD3 | 78 |
| SD | 77 |
| TB | 77 |
| R | 76 |
| PA | 76 |
| L. | 76 |
| Korea | 76 |
| IC | 76 |
| GFC | 76 |
| Clinical | 76 |
| Centre | 76 |
| ± | 75 |
| Association | 75 |
| ECMO | 74 |
| Brazil | 74 |
| IFR | 73 |
| October | 73 |
| PTH | 73 |
| Survey | 73 |
| sha | 73 |
| dl | 72 |
| B. | 72 |
| • | 71 |
| IgM | 71 |
| H | 71 |
| December | 71 |
| _ | 70 |
| Methods | 70 |
| HUS | 70 |
| HLA | 70 |
| TNF | 69 |
| East | 69 |
| Diseases | 69 |
| CoV | 68 |
| Program | 68 |
| Human | 67 |
| American | 67 |
| m2 | 66 |
| MMF | 66 |
| D. | 66 |
| mTOR | 65 |
| Wuhan | 65 |
| R. | 65 |
| DOI | 65 |
| lymphopenia | 64 |
| Unit | 64 |
| IgE | 64 |
| Control | 64 |
| CHD | 63 |
| Nephrology | 62 |
| Tx | 62 |
| SLE | 61 |
| Cox | 61 |
| range | 60 |
| Review | 60 |
| International | 60 |
| India | 60 |
| Australia | 60 |
| immunosenescence | 60 |
| Society | 59 |
| RT | 59 |
| P. | 59 |
| June | 59 |
| France | 59 |
| Analysis | 59 |
| Patient | 58 |
| NC | 58 |
| meta | 58 |
| July | 57 |
| Science | 57 |
| TCR | 56 |
| Public | 56 |
| AFC | 56 |
| Y | 55 |
| P | 55 |
| Na | 55 |
| CR | 55 |
| Physical | 54 |
| INSPIRE | 54 |
| EEG | 54 |
| General | 53 |
| Development | 53 |
| G. | 53 |
| IPF | 53 |
| HCV | 53 |
| Prevention | 53 |
| PID | 53 |
| London | 52 |
| CC | 52 |
| Data | 52 |
| Immunosenescence | 52 |
| Scale | 52 |
| mRNA | 52 |
| min | 52 |
| p<0.0001 | 52 |
| ng | 51 |
| der | 51 |
| Project | 51 |
| Cancer | 51 |
| IgAN | 50 |
| Ca | 50 |
| PI | 50 |
| Objective | 50 |
| Organization | 50 |
| Working | 49 |
| SDS | 49 |
| Parkinson | 49 |
| August | 49 |
| AGE | 49 |
| V | 48 |
| IL-2 | 48 |
| E | 48 |
| Chinese | 48 |
| America | 48 |
| IR | 47 |
| ELISA | 47 |
| MERS | 47 |
| LV | 47 |
| Pediatrics | 47 |
| mmol | 46 |
| System | 46 |
| Report | 46 |
| November | 46 |
| Mitochondrial | 46 |
| MR | 46 |
| Life | 46 |
| IVIG | 46 |
| February | 46 |
| ADL | 46 |
| HR | 45 |
| Assessment | 45 |
| CPB | 45 |
| Intensive | 45 |
| MI | 45 |
| Treg | 45 |
| IL6 | 44 |
| Adults | 44 |
| CAD | 44 |
| DM | 44 |
| Geriatric | 44 |
| Population | 44 |
| State | 44 |
| Statistics | 44 |
| ml | 44 |
| mycophenolate | 44 |
| prednisone | 44 |
| Generation | 43 |
| CFR | 43 |
| DNA | 43 |
| Foundation | 43 |
| Global | 43 |
| Heart | 43 |
| Registry | 43 |
| Americans | 42 |
| VEGF | 42 |
| Urban | 42 |
| Ontario | 42 |
| Infectious | 42 |
| Immune | 42 |
| HCoVs | 42 |
| Figure | 42 |
| ATP | 42 |
| ANCA | 42 |
| Chronic | 41 |
| CA | 41 |
| MD | 41 |
| C3 | 41 |
| Asia | 41 |
| HD | 41 |
| Gerontology | 41 |
| SES | 41 |
| Impact | 41 |
| K. | 41 |
| Kingdom | 41 |
| NF | 41 |
| W. | 41 |
| CDC | 40 |
| EU | 40 |
| College | 40 |
| GT | 40 |
| Asthma | 40 |
| AUC | 40 |
| GA | 40 |
| ND | 40 |
| HTN | 40 |
| pH | 40 |
| Near | 40 |
| Street | 40 |
| Sweden | 40 |
| Mediterranean | 40 |
| LPS | 39 |
| Aging | 39 |
| GS | 39 |
| Geroscience | 39 |
| Great | 39 |
| HT | 39 |
| Influenza | 39 |
| NAD | 39 |
| Mini | 39 |
| NHS | 39 |
| NIH | 39 |
| Paediatric | 39 |
| Risk | 39 |
| SBP | 39 |
| WHO | 39 |
| HLH | 38 |
| CsA | 38 |
| Geriatrics | 38 |
| H. | 38 |
| Finland | 38 |
| Healthy | 38 |
| Quality | 38 |
| WT | 38 |
| mofetil | 38 |
| Mental | 38 |
| MNA | 37 |
| ABPM | 37 |
| Alport | 37 |
| Child | 37 |
| DXA | 37 |
| ED | 37 |
| BY | 37 |
| Objectives | 37 |
| School | 37 |
| Short | 37 |
| Treatment | 37 |
| U.S. | 37 |
| los | 37 |
| Primary | 37 |
| MA | 36 |
| CNI | 36 |
| Dent | 36 |
| Fried | 36 |
| HSC | 36 |
| ROC | 36 |
| MMSE | 36 |
| Mocchegiani | 36 |
| Services | 36 |
| Singapore | 36 |
| St. | 36 |
| SMA | 35 |
| MN | 35 |
| Republic | 35 |
| MCP-1 | 35 |
| Turkey | 35 |
| p<0.05 | 35 |
| fi | 35 |
| RDS | 34 |
| Cohort | 34 |
| EC | 34 |
| FI | 34 |
| GN | 34 |
| People | 34 |
| Metformin | 34 |
| RPD | 34 |
| Stress | 34 |
| Supplementary | 34 |
| Women | 34 |
| pg | 34 |
| podocyte | 34 |
| IADL | 33 |
| ADA | 33 |
| ANOVA | 33 |
| Brain | 33 |
| CP | 33 |
| Case | 33 |
| Eastern | 33 |
| mm | 33 |
| Immunology | 33 |
| LA | 33 |
| MCD | 33 |
| PIDD | 33 |
| PP | 33 |
| novo | 33 |
| HF | 32 |
| 8) | 32 |
| ALS | 32 |
| CSA | 32 |
| DS | 32 |
| Sea | 32 |
| Hittite | 32 |
| MAP | 32 |
| Vancouver | 32 |
| Lung | 32 |
| SSNS | 31 |
| Cardiovascular | 31 |
| DR | 31 |
| Hepatitis | 31 |
| Ig | 31 |
| Rapamycin | 31 |
| Ministry | 31 |
| SY | 31 |
| Service | 31 |
| Tregs | 31 |
| V. | 31 |
| W | 31 |
| β | 31 |
| μmol | 31 |
| BNP | 30 |
| Central | 30 |
| Clinic | 30 |
| Cr | 30 |
| Dutch | 30 |
| ER | 30 |
| HBoV2 | 30 |
| Journal | 30 |
| Ireland | 30 |
| IQR | 30 |
| MCNS | 30 |
| Sciences | 30 |
| MHC | 30 |
| sec | 30 |
| T. | 30 |
| st | 30 |
| SIR | 30 |
| Questionnaire | 30 |
| Protein | 30 |
| Philistines | 30 |
| Neurology | 29 |
| ARF | 29 |
| Commission | 29 |
| DMD | 29 |
| De | 29 |
| Depression | 29 |
| Egypt | 29 |
| GBM | 29 |
| Lee | 29 |
| Meta | 29 |
| P<0.001 | 29 |
| TCL | 29 |
| el | 29 |
| inflammasome | 29 |
| nan | 29 |
| sarcopenic | 29 |
| van | 29 |
| Novel | 29 |
| α | 29 |
| IUGR | 28 |
| Daily | 28 |
| HC | 28 |
| GP | 28 |
| Family | 28 |
| Factor | 28 |
| CARD11 | 28 |
| Cognitive | 28 |
| Canadian | 28 |
| CYAR | 28 |
| BW | 28 |
| HIVAN | 28 |
| TREC | 28 |
| LN | 28 |
| Therapy | 28 |
| Mortality | 28 |
| i | 28 |
| cm | 28 |
| WES | 28 |
| association | 28 |
| Schwartz | 28 |
| Royal | 28 |
| Renal | 28 |
| RAG1 | 28 |
| PE | 28 |
| F. | 27 |
| IGF | 27 |
| I. | 27 |
| Healthcare | 27 |
| HBV | 27 |
| GBS | 27 |
| Amsterdam | 27 |
| Emergency | 27 |
| Committee | 27 |
| Chi | 27 |
| CS | 27 |
| CD | 27 |
| Liu | 27 |
| IL-1 | 27 |
| SF | 27 |
| MAPK | 27 |
| Plague | 27 |
| MPGN | 27 |
| Zacher | 27 |
| Spearman | 27 |
| nephrin | 27 |
| Proteinuria | 27 |
| Taiwan | 27 |
| Pearson | 27 |
| OR | 27 |
| N. | 27 |
| Model | 27 |
| Mexico | 27 |
| PWV | 27 |
| FFP | 26 |
| Hb | 26 |
| HAART | 26 |
| Function | 26 |
| Fisher | 26 |
| AR | 26 |
| Census | 26 |
| Cell | 26 |
| ADR | 26 |
| ID | 26 |
| Henoch | 26 |
| IGF-1 | 26 |
| SEM | 26 |
| IL-4 | 26 |
| Immunodeficiency | 26 |
| Manchester | 26 |
| Mg | 26 |
| North | 26 |
| Rudolph | 26 |
| UF | 26 |
| Use | 26 |
| p>0.05 | 26 |
| IL | 26 |
| H1N1 | 25 |
| Government | 25 |
| MSM | 25 |
| LD | 25 |
| Epidemiology | 25 |
| G1 | 25 |
| ACTH | 25 |
| Diet | 25 |
| CM | 25 |
| Baltes | 25 |
| BC | 25 |
| Asian | 25 |
| Li | 25 |
| ASD | 25 |
| Nutrition | 25 |
| Y. | 25 |
| Performance | 25 |
| min/1.73 | 25 |
| r(113 | 25 |
| hypogammaglobulinemia | 25 |
| e. | 25 |
| metformin | 25 |
| Virus | 25 |
| Trial | 25 |
| T4 | 25 |
| Systematic | 25 |
| RR | 25 |
| RA | 25 |
| LP | 24 |
| ACEI | 24 |
| AMI | 24 |
| Chen | 24 |
| England | 24 |
| English | 24 |
| HPV | 24 |
| Inflammaging | 24 |
| LDL | 24 |
| Mumbai | 24 |
| QOL | 24 |
| Time | 24 |
| West | 24 |
| fl | 24 |
| hypercalciuria | 24 |
| las | 24 |
| microalbuminuria | 24 |
| NY | 24 |
| · | 24 |
| Network | 23 |
| EPO | 23 |
| HTLV | 23 |
| HH | 23 |
| GVHD | 23 |
| Elderly | 23 |
| Acute | 23 |
| DMSA | 23 |
| Battery | 23 |
| Austria | 23 |
| AT | 23 |
| AFP | 23 |
| IL-18 | 23 |
| TRPC6 | 23 |
| Neurological | 23 |
| healthspan | 23 |
| Outcomes | 23 |
| β1 | 23 |
| monocyte | 23 |
| max | 23 |
| nd | 23 |
| San | 23 |
| SARC | 23 |
| Peoples | 23 |
| Patients | 23 |
| PRISM | 23 |
| Centers | 22 |
| HBoV | 22 |
| FMD | 22 |
| Examination | 22 |
| Dublin | 22 |
| Drug | 22 |
| Dementia | 22 |
| David | 22 |
| ASM | 22 |
| Ccr | 22 |
| CD19 | 22 |
| Bureau | 22 |
| Board | 22 |
| Blanchflower | 22 |
| APN | 22 |
| HS | 22 |
| HRV | 22 |
| NIAID | 22 |
| IU | 22 |
| Toulouse | 22 |
| anti | 22 |
| Wilcoxon | 22 |
| Western | 22 |
| Wang | 22 |
| Van | 22 |
| VZV | 22 |
| Transplantation | 22 |
| Introduction | 22 |
| Systems | 22 |
| OA | 22 |
| p<0,001 | 22 |
| Metabolic | 22 |
| MBP | 22 |
| John | 22 |
| PAI-1 | 22 |
| Empire | 21 |
| Laboratory | 21 |
| LVH | 21 |
| LOS | 21 |
| Kidney | 21 |
| Information | 21 |
| IM | 21 |
| Front | 21 |
| Commons | 21 |
| EMG | 21 |
| Creative | 21 |
| Barthel | 21 |
| Aim | 21 |
| AMD | 21 |
| ACE | 21 |
| Lowe | 21 |
| Living | 21 |
| Los | 21 |
| MV | 21 |
| SGA | 21 |
| κB | 21 |
| mL | 21 |
| Utrecht | 21 |
| Trust | 21 |
| Tokyo | 21 |
| TMPRSS2 | 21 |
| Schönlein | 21 |
| Technology | 21 |
| Region | 21 |
| RRF | 21 |
| RI | 21 |
| RAS | 21 |
| Poisson | 21 |
| NI | 21 |
| RTI | 21 |
| NBS | 21 |
| Faculty | 20 |
| Ebola | 20 |
| Epidemiological | 20 |
| IGSC | 20 |
| GH | 20 |
| HPLC | 20 |
| IG | 20 |
| CTX | 20 |
| CyA | 20 |
| AS | 20 |
| CH50 | 20 |
| CF | 20 |
| CAYP | 20 |
| Basic | 20 |
| Bartter | 20 |
| Barcelona | 20 |
| Access | 20 |
| Infection | 20 |
| AIRE | 20 |
| IMT | 20 |
| Young | 20 |
| Middle | 20 |
| SMI | 20 |
| Muscle | 20 |
| ranibizumab | 20 |
| p=0.01 | 20 |
| nephropathy | 20 |
| n=6 | 20 |
| VAS | 20 |
| Seoul | 20 |
| Section | 20 |
| n=10 | 20 |
| RTX | 20 |
| PSP | 20 |
| PS | 20 |
| PK | 20 |
| P4 | 20 |
| Ormond | 20 |
| Ob | 20 |
| RBC | 20 |
| NPHS2 | 20 |
| Med | 19 |
| Friendly | 19 |
| Guangdong | 19 |
| HFO | 19 |
| MVPA | 19 |
| King | 19 |
| LM | 19 |
| MCI | 19 |
| Evaluation | 19 |
| Francisco | 19 |
| AH | 19 |
| Day | 19 |
| DPP4 | 19 |
| California | 19 |
| CLD | 19 |
| CK | 19 |
| CD34 | 19 |
| Blood | 19 |
| BIA | 19 |
| AI | 19 |
| -80 | 19 |
| Markov | 19 |
| KD | 19 |
| NGS | 19 |
| TM | 19 |
| vivo | 19 |
| tacrolimus | 19 |
| sirolimus | 19 |
| mHealth | 19 |
| hepatitis | 19 |
| cortex | 19 |
| Wu | 19 |
| White | 19 |
| Tacrolimus | 19 |
| NO2 | 19 |
| Sub | 19 |
| SB | 19 |
| Rotterdam | 19 |
| Rochester | 19 |
| Robert | 19 |
| Programme | 19 |
| PCD | 19 |
| Nations | 19 |
| NR | 19 |
| Studies | 19 |
| Doppler | 18 |
| DM2 | 18 |
| Dawley | 18 |
| Disability | 18 |
| HBoV3 | 18 |
| Exercise | 18 |
| Factors | 18 |
| G2 | 18 |
| Glenn | 18 |
| Covid-19 | 18 |
| DBP | 18 |
| CD27 | 18 |
| CoV-1 | 18 |
| Chicago | 18 |
| CTLA4 | 18 |
| CRB | 18 |
| British | 18 |
| Belgium | 18 |
| Anatolia | 18 |
| Alberta | 18 |
| ARI | 18 |
| Immunol | 18 |
| ICD | 18 |
| Effect | 18 |
| ML | 18 |
| Related | 18 |
| von | 18 |
| Mas | 18 |
| p= | 18 |
| hs | 18 |
| del | 18 |
| Yang | 18 |
| TC | 18 |
| T2 | 18 |
| Saharan | 18 |
| SE | 18 |
| Respiratory | 18 |
| haemodialysis | 18 |
| Rating | 18 |
| O. | 18 |
| Michael | 18 |
| Q10 | 18 |
| Nursing | 18 |
| NHE3 | 18 |
| Mechanisms | 18 |
| PMT | 18 |
| Poland | 18 |
| Province | 18 |
| DC | 17 |
| HN | 17 |
| Division | 17 |
| Duffy | 17 |
| FMF | 17 |
| HB | 17 |
| HDL | 17 |
| HIES | 17 |
| IBU | 17 |
| HRT | 17 |
| IBM | 17 |
| IL1β | 17 |
| INS | 17 |
| IPD | 17 |
| Iron | 17 |
| Cl | 17 |
| KCL | 17 |
| Congress | 17 |
| Appendix | 17 |
| Cities | 17 |
| Charles | 17 |
| LVM | 17 |
| ADPKD | 17 |
| AED | 17 |
| ALPS | 17 |
| AST | 17 |
| Activity | 17 |
| Agency | 17 |
| Associated | 17 |
| BMD | 17 |
| Bangladesh | 17 |
| Based | 17 |
| Bcl-2 | 17 |
| Burden | 17 |
| CI95 | 17 |
| CID | 17 |
| Kaplan | 17 |
| Chile | 17 |
| MAVS | 17 |
| administration | 17 |
| TIA | 17 |
| TLR4 | 17 |
| TNFa | 17 |
| TSH | 17 |
| Thailand | 17 |
| USIDNET | 17 |
| acid | 17 |
| aflibercept | 17 |
| SDMA | 17 |
| dopa | 17 |
| g. | 17 |
| i. | 17 |
| medRxiv | 17 |
| social | 17 |
| −/− | 17 |
| Management | 17 |
| Sprague | 17 |
| X | 17 |
| SASP | 17 |
| Ottawa | 17 |
| Russia | 17 |
| Mitochondria | 17 |
| Mycobacterium | 17 |
| NAG | 17 |
| NLRP3 | 17 |
| Nagoya | 17 |
| Old | 17 |
| Meier | 17 |
| PHB | 17 |
| Pandemic | 17 |
| Portugal | 17 |
| PubMed | 17 |
| Pulmonary | 17 |
| RHD | 17 |
| PMN | 17 |
| GLIM | 16 |
| Economic | 16 |
| FEV | 16 |
| Failure | 16 |
| Fanconi | 16 |
| First | 16 |
| Fischer | 16 |
| GI | 16 |
| Gyeonggi | 16 |
| GM | 16 |
| GOF | 16 |
| Greece | 16 |
| H20 | 16 |
| H2AX | 16 |
| HRQoL | 16 |
| HSN | 16 |
| ERK | 16 |
| ETT | 16 |
| AF | 16 |
| Dysfunction | 16 |
| Departments | 16 |
| ACT | 16 |
| Integrated | 16 |
| ANA | 16 |
| APC | 16 |
| ARB | 16 |
| AZA | 16 |
| Allergy | 16 |
| Ann | 16 |
| BCG | 16 |
| Baldassar | 16 |
| CG | 16 |
| COVerAGE | 16 |
| Clin | 16 |
| Cohen | 16 |
| DB | 16 |
| DHA | 16 |
| DSS | 16 |
| Infections | 16 |
| MOG | 16 |
| Irish | 16 |
| Southern | 16 |
| T1 | 16 |
| Thai | 16 |
| VT | 16 |
| Youth | 16 |
| Z | 16 |
| benefi | 16 |
| chi | 16 |
| den | 16 |
| kB | 16 |
| mo | 16 |
| p<0 | 16 |
| p<0,05 | 16 |
| p=0.04 | 16 |
| Lopez | 16 |
| sera | 16 |
| ug | 16 |
| ~s | 16 |
| Surveillance | 16 |
| rhGH | 16 |
| Sirolimus | 16 |
| NPHP1 | 16 |
| Score | 16 |
| MRSA | 16 |
| Mann | 16 |
| Molecular | 16 |
| NDI | 16 |
| NH | 16 |
| NO | 16 |
| Madrid | 16 |
| Nrf2 | 16 |
| SPSS | 16 |
| PO | 16 |
| PTLD | 16 |
| Pre | 16 |
| RTD | 16 |
| Rituximab | 16 |
| PAN | 16 |
| Eye | 15 |
| FTY720 | 15 |
| Food | 15 |
| GPs | 15 |
| Gene | 15 |
| IL-12 | 15 |
| James | 15 |
| IVIg | 15 |
| Inner | 15 |
| Iran | 15 |
| LDH | 15 |
| LVMI | 15 |
| Lima | 15 |
| Efficacy | 15 |
| Ethics | 15 |
| Canadians | 15 |
| Denmark | 15 |
| Delta | 15 |
| Database | 15 |
| DOCK8 | 15 |
| County | 15 |
| Colombia | 15 |
| Clark | 15 |
| Childhood | 15 |
| Beijing | 15 |
| BM | 15 |
| Angeles | 15 |
| Aegean | 15 |
| ANC | 15 |
| ADMA | 15 |
| MCR | 15 |
| Lyme | 15 |
| Latin | 15 |
| MDA | 15 |
| Wistar | 15 |
| Test | 15 |
| Times | 15 |
| UB | 15 |
| UT | 15 |
| WBC | 15 |
| Wales | 15 |
| Zittoun | 15 |
| Security | 15 |
| angiotensinogen | 15 |
| gr | 15 |
| interleukin-6 | 15 |
| ® | 15 |
| ° | 15 |
| Measles | 15 |
| Team | 15 |
| n=12 | 15 |
| SF-36 | 15 |
| PIP | 15 |
| SDNS | 15 |
| NADPH | 15 |
| NLP | 15 |
| Nature | 15 |
| PH | 15 |
| PHT | 15 |
| γ | 15 |
| PMA | 15 |
| Res | 15 |
| Phase | 15 |
| Phenotype | 15 |
| Q | 15 |
| Panel | 15 |
| ECS | 14 |
| ECM | 14 |
| ECG | 14 |
| E2 | 14 |
| Dr. | 14 |
| DA | 14 |
| DEX | 14 |
| DD | 14 |
| Cross | 14 |
| Cronbach | 14 |
| FA | 14 |
| Council | 14 |
| Environment | 14 |
| HUTT | 14 |
| FGF-2 | 14 |
| FH | 14 |
| Forest | 14 |
| Framework | 14 |
| GC | 14 |
| Golant | 14 |
| I(t | 14 |
| ICC | 14 |
| ICOPE | 14 |
| IHD | 14 |
| IKAROS | 14 |
| CVVH | 14 |
| Characteristics | 14 |
| Ab | 14 |
| CTLA-4 | 14 |
| CRC | 14 |
| -6 | 14 |
| AFM | 14 |
| ALM | 14 |
| ANGPTL3 | 14 |
| AP | 14 |
| APECED | 14 |
| APSGN | 14 |
| AQP1 | 14 |
| ARPKD | 14 |
| AU | 14 |
| Institutes | 14 |
| Abs | 14 |
| Activities | 14 |
| African | 14 |
| Aichi | 14 |
| Akt | 14 |
| Ancient | 14 |
| Anti | 14 |
| Ark | 14 |
| BRI | 14 |
| BV | 14 |
| Berg | 14 |
| CAS | 14 |
| CBD | 14 |
| COPA | 14 |
| IL-10 | 14 |
| HIV-1 | 14 |
| Int | 14 |
| macular | 14 |
| Screening | 14 |
| Se | 14 |
| Spanish | 14 |
| Survanta | 14 |
| Tuberculosis | 14 |
| Type | 14 |
| Weiss | 14 |
| Whitney | 14 |
| Yu | 14 |
| che | 14 |
| dL | 14 |
| health | 14 |
| mass | 14 |
| SR | 14 |
| miRs | 14 |
| microRNA | 14 |
| n= | 14 |
| n=11 | 14 |
| p=0.000 | 14 |
| p=0.001 | 14 |
| p=0.02 | 14 |
| Kt | 14 |
| square | 14 |
| und | 14 |
| zoster | 14 |
| ν | 14 |
| Sandra | 14 |
| sTfR | 14 |
| Rag1 | 14 |
| Nairobi | 14 |
| RCT | 14 |
| LT | 14 |
| LTCI | 14 |
| MFS | 14 |
| MPA | 14 |
| MPO | 14 |
| NGAL | 14 |
| NL63 | 14 |
| NMR | 14 |
| NPHP | 14 |
| NYC | 14 |
| MDS | 14 |
| Neurol | 14 |
| PPD | 14 |
| Nicotinamide | 14 |
| Practice | 14 |
| Psychology | 14 |
| PRN | 14 |
| Policy | 14 |
| PHQ-9 | 14 |
| PD-1 | 14 |
| OI | 14 |
| Nutritional | 14 |
| Northern | 14 |
| EMCO | 13 |
| ESR | 13 |
| ET | 13 |
| El | 13 |
| Environmental | 13 |
| Epstein | 13 |
| FAS | 13 |
| HCT | 13 |
| HL | 13 |
| IBD | 13 |
| IVF | 13 |
| ICP | 13 |
| IFNP | 13 |
| IL-21 | 13 |
| IL-8 | 13 |
| IRB | 13 |
| Initiative | 13 |
| Inventory | 13 |
| Jews | 13 |
| Joseph | 13 |
| EB | 13 |
| Kenya | 13 |
| EGF | 13 |
| CD28 | 13 |
| Dravet | 13 |
| DI | 13 |
| Lancet | 13 |
| (= | 13 |
| AEs | 13 |
| APD | 13 |
| ATN | 13 |
| Act | 13 |
| Altman | 13 |
| Angiotensin | 13 |
| BCS | 13 |
| Boston | 13 |
| C6 | 13 |
| CO | 13 |
| CPAP | 13 |
| CV | 13 |
| Centres | 13 |
| Cochrane | 13 |
| Complex | 13 |
| Consensus | 13 |
| Consortium | 13 |
| Controlled | 13 |
| DHR | 13 |
| Kim | 13 |
| nephrocalcinosis | 13 |
| Loneliness | 13 |
| ResNet | 13 |
| SC | 13 |
| Special | 13 |
| TBE | 13 |
| TLR | 13 |
| Teico | 13 |
| Transplant | 13 |
| UUO | 13 |
| WD | 13 |
| WT1 | 13 |
| Washington | 13 |
| Wilms | 13 |
| Zinc | 13 |
| Zn | 13 |
| bocavirus | 13 |
| everolimus | 13 |
| n=5 | 13 |
| p=0.003 | 13 |
| rapamycin | 13 |
| ts | 13 |
| | | 13 |
| Longitudinal | 13 |
| Response | 13 |
| Zhou | 13 |
| Regional | 13 |
| PM2.5 | 13 |
| MC | 13 |
| Ratio | 13 |
| MRS | 13 |
| Mark | 13 |
| Method | 13 |
| N=1 | 13 |
| Nephrin | 13 |
| Nigeria | 13 |
| PKD | 13 |
| NT | 13 |
| PSS | 13 |
| Paris | 13 |
| Park | 13 |
| Plan | 13 |
| Pneumonia | 13 |
| Post | 13 |
| RDD | 13 |
| PRISMA | 13 |
| RE | 13 |
| Randomized | 13 |
| Education | 12 |
| Fund | 12 |
| HFOV | 12 |
| HCPs | 12 |
| GAD-7 | 12 |
| Future | 12 |
| FK | 12 |
| ForeseeHome | 12 |
| Fontan | 12 |
| FS | 12 |
| Elder | 12 |
| Hispanics | 12 |
| HPA | 12 |
| Long | 12 |
| Hu | 12 |
| ICUs | 12 |
| IDF | 12 |
| IH | 12 |
| IL-13 | 12 |
| Insurance | 12 |
| Interventions | 12 |
| KT | 12 |
| Lluch | 12 |
| M1 | 12 |
| MAS | 12 |
| MFI | 12 |
| EQ-5D | 12 |
| EWGSOP2 | 12 |
| AGT | 12 |
| EPIC | 12 |
| C1q | 12 |
| NE | 12 |
| ACS | 12 |
| ADE | 12 |
| ADEM | 12 |
| ADHD | 12 |
| Abstracts | 12 |
| Action | 12 |
| BK | 12 |
| Barr | 12 |
| Bayes | 12 |
| Bell | 12 |
| Bland | 12 |
| CAPD | 12 |
| EPA | 12 |
| CD147 | 12 |
| CDG | 12 |
| CHO | 12 |
| CIT | 12 |
| CO2 | 12 |
| COL4A5 | 12 |
| COV-2 | 12 |
| COVID | 12 |
| Calgary | 12 |
| Communities | 12 |
| Costanza | 12 |
| EMR | 12 |
| Manhattan | 12 |
| OFMU | 12 |
| NFKB2 | 12 |
| XLA | 12 |
| Support | 12 |
| TA | 12 |
| TG | 12 |
| TP | 12 |
| TUG | 12 |
| Transmission | 12 |
| Trials | 12 |
| Union | 12 |
| VL | 12 |
| Victoria | 12 |
| WG | 12 |
| Williams | 12 |
| anakinra | 12 |
| Springer | 12 |
| arthralgia | 12 |
| enteropathy | 12 |
| haploinsufficiency | 12 |
| methotrexate | 12 |
| miR-181a | 12 |
| mito | 12 |
| n=13 | 12 |
| sich | 12 |
| tHcy | 12 |
| trans | 12 |
| × | 12 |
| NPHS1 | 12 |
| Standard | 12 |
| basiliximab | 12 |
| Shiraz | 12 |
| Pakistan | 12 |
| − | 12 |
| Selenium | 12 |
| Older | 12 |
| Organ | 12 |
| Oswald | 12 |
| Oxford | 12 |
| PET | 12 |
| PLT | 12 |
| PNE | 12 |
| POIG | 12 |
| PTEN | 12 |
| PU | 12 |
| PCNA | 12 |
| Pathology | 12 |
| Seattle | 12 |
| Scr | 12 |
| Scientific | 12 |
| SRL | 12 |
| SCD | 12 |
| SNP | 12 |
| SCA | 12 |
| SAVI | 12 |
| RTT | 12 |
| Pick | 12 |
| Peter | 12 |
| FM | 11 |
| GIS | 11 |
| GD | 11 |
| GBD | 11 |
| French | 11 |
| Fi02 | 11 |
| Fallzahlen | 11 |
| EXTL3 | 11 |
| FFA | 11 |
| Evans | 11 |
| Eq | 11 |
| Edmonton | 11 |
| Director | 11 |
| EWGSOP | 11 |
| EAE | 11 |
| HA | 11 |
| GSH | 11 |
| KO | 11 |
| HEV | 11 |
| Inflammatory | 11 |
| DDD | 11 |
| Lawton | 11 |
| Law | 11 |
| La | 11 |
| LMWH | 11 |
| Jan | 11 |
| Inflamm | 11 |
| HP | 11 |
| Incidence | 11 |
| Immunosuppression | 11 |
| Ill | 11 |
| IRT | 11 |
| High | 11 |
| HSP70 | 11 |
| Daniel | 11 |
| Activation | 11 |
| DAR | 11 |
| Cytomegalovirus | 11 |
| CFS | 11 |
| CCA | 11 |
| CB4 | 11 |
| BSA | 11 |
| Autophagy | 11 |
| Attribution | 11 |
| Alb | 11 |
| Library | 11 |
| Abbott | 11 |
| ASMR | 11 |
| ASA | 11 |
| ANF | 11 |
| AGA | 11 |
| ACR | 11 |
| AB | 11 |
| CHC | 11 |
| CHF | 11 |
| CHS | 11 |
| Cardiology | 11 |
| Cruz | 11 |
| Critical | 11 |
| Costa | 11 |
| Comprehensive | 11 |
| Collapse | 11 |
| Classification | 11 |
| Cardiac | 11 |
| CIs | 11 |
| CX3CL1 | 11 |
| CVP | 11 |
| CVC | 11 |
| CSW | 11 |
| CMM | 11 |
| CLCNKB | 11 |
| Levy | 11 |
| HIV-2 | 11 |
| Lin | 11 |
| Stroke | 11 |
| Zhang | 11 |
| ZX008 | 11 |
| Wong | 11 |
| Wilson | 11 |
| VUS | 11 |
| Units | 11 |
| Twenge | 11 |
| Total | 11 |
| Th17 | 11 |
| Tfh | 11 |
| TX | 11 |
| TS | 11 |
| TBR | 11 |
| Sustainable | 11 |
| Student | 11 |
| disease | 11 |
| doc_id | 11 |
| en | 11 |
| p=0.004 | 11 |
| Longevity | 11 |
| ≥80 | 11 |
| uropathy | 11 |
| ro | 11 |
| post | 11 |
| para | 11 |
| p=0.002 | 11 |
| es | 11 |
| microsomal | 11 |
| miRNA | 11 |
| mean | 11 |
| inotropic | 11 |
| hyperoxaluria | 11 |
| herpes | 11 |
| Structure | 11 |
| hepatosplenomegaly | 11 |
| Status | 11 |
| P3 | 11 |
| OC43 | 11 |
| NMN | 11 |
| NICU | 11 |
| NF1 | 11 |
| NAD+ | 11 |
| Mycoplasma | 11 |
| Multiple | 11 |
| Mainland | 11 |
| MTX | 11 |
| MPTP | 11 |
| MPS | 11 |
| MNE | 11 |
| MMR | 11 |
| Serum | 11 |
| ME | 11 |
| Office | 11 |
| Montreal | 11 |
| P=0.001 | 11 |
| Peru | 11 |
| STAT3 | 11 |
| PCV | 11 |
| SCC | 11 |
| Rockwood | 11 |
| Register | 11 |
| RV | 11 |
| Regulation | 11 |
| SVM | 11 |
| Pacific | 11 |
| POS | 11 |
| PHA | 11 |
| 11 | |
| Parker | 11 |
| PDC | 11 |
| José | 10 |
| Hamilton | 10 |
| House | 10 |
| ICH | 10 |
| Joint | 10 |
| IGT | 10 |
| IHC | 10 |
| IL1 | 10 |
| HSV | 10 |
| IL-2R | 10 |
| FOS | 10 |
| Gray | 10 |
| Gen | 10 |
| GDP | 10 |
| Franceschi | 10 |
| FOXP3 | 10 |
| FFQ | 10 |
| FEV1 | 10 |
| FADD | 10 |
| LSAY | 10 |
| Extension | 10 |
| LOA | 10 |
| Mass | 10 |
| Leiden | 10 |
| Lithuania | 10 |
| Epidemic | 10 |
| Mitophagy | 10 |
| Minnesota | 10 |
| Miller | 10 |
| Millennials | 10 |
| Mayo | 10 |
| Mary | 10 |
| Mannheim | 10 |
| Macular | 10 |
| MTHFR | 10 |
| MRs | 10 |
| MPC5 | 10 |
| MM | 10 |
| MIF | 10 |
| MG | 10 |
| MEP | 10 |
| MEFV | 10 |
| MCA | 10 |
| M2 | 10 |
| Eurobarometer | 10 |
| B12 | 10 |
| EMS | 10 |
| Biomarkers | 10 |
| Beck | 10 |
| Bax | 10 |
| Bartonella | 10 |
| Baltimore | 10 |
| BS | 10 |
| BRFSS | 10 |
| BMIS | 10 |
| Nephrotic | 10 |
| BF | 10 |
| BAU | 10 |
| Apoe | 10 |
| Almeida | 10 |
| Academy | 10 |
| AQP2 | 10 |
| AOM | 10 |
| ANP | 10 |
| AM | 10 |
| ALT | 10 |
| AG | 10 |
| Belo | 10 |
| Biomedical | 10 |
| Duchenne | 10 |
| Body | 10 |
| Down | 10 |
| Demographic | 10 |
| DCs | 10 |
| Czech | 10 |
| Covenant | 10 |
| Cov-2 | 10 |
| Columbia | 10 |
| Chief | 10 |
| Caenorhabditis | 10 |
| CYP | 10 |
| CRI | 10 |
| CMAP | 10 |
| CLL | 10 |
| CKiD | 10 |
| CHH | 10 |
| CGA | 10 |
| CDAD | 10 |
| C4 | 10 |
| Bone | 10 |
| NSCID | 10 |
| n=17 | 10 |
| Neutrophil | 10 |
| Yip | 10 |
| Watson | 10 |
| Vmax | 10 |
| Vit | 10 |
| Vietnam | 10 |
| Valpha | 10 |
| VCUG | 10 |
| UAE | 10 |
| Training | 10 |
| Todesfälle | 10 |
| Tissue | 10 |
| Term | 10 |
| Tac | 10 |
| TST | 10 |
| TBM | 10 |
| T3 | 10 |
| Surveys | 10 |
| Surinamese | 10 |
| Surgery | 10 |
| Stephan | 10 |
| Work | 10 |
| anterior | 10 |
| Staphylococcus | 10 |
| author(s | 10 |
| Non | 10 |
| −1 | 10 |
| ~e | 10 |
| t. | 10 |
| rst | 10 |
| qPCR | 10 |
| podocin | 10 |
| plasmacytoid | 10 |
| periventricular | 10 |
| perampanel | 10 |
| pHi | 10 |
| ophthalmoplegia | 10 |
| n=20 | 10 |
| miRNAs | 10 |
| metallothionein | 10 |
| infecciones | 10 |
| group | 10 |
| glomerulopathy | 10 |
| corpus | 10 |
| Step | 10 |
| biopsy | 10 |
| Sleep | 10 |
| Porto | 10 |
| Philadelphia | 10 |
| Pereira | 10 |
| PSA | 10 |
| PPV | 10 |
| PM | 10 |
| PJP | 10 |
| PI3 | 10 |
| PG | 10 |
| PCA | 10 |
| P450 | 10 |
| P2 | 10 |
| P1 | 10 |
| Oxidative | 10 |
| Oliveira | 10 |
| Odds | 10 |
| Obesity | 10 |
| OAS1 | 10 |
| Sir | 10 |
| Northwell | 10 |
| Philippines | 10 |
| PDGF | 10 |
| Poverty | 10 |
| Retirement | 10 |
| Senior | 10 |
| Sex | 10 |
| Preventive | 10 |
| Sarcopenic | 10 |
| ST | 10 |
| SIF | 10 |
| SHM | 10 |
| SA | 10 |
| S1 | 10 |
| Richard | 10 |
| SAS | 10 |
| Ramesses | 10 |
| RF | 10 |
| RAI | 10 |
| QMT | 10 |
| Protection | 10 |
| Reporting | 10 |
| Promotion | 10 |
| Professor | 10 |
| Hg | 9 |
| HAV | 9 |
| Grant | 9 |
| Green | 9 |
| Guillain | 9 |
| HK | 9 |
| HHV6 | 9 |
| Hittites | 9 |
| Herpes | 9 |
| Graham | 9 |
| Gram | 9 |
| ESP | 9 |
| GSS | 9 |
| GDNF | 9 |
| Fallot | 9 |
| Experience | 9 |
| Executive | 9 |
| Etanercept | 9 |
| Elizabeth | 9 |
| Effectiveness | 9 |
| ESLD | 9 |
| ERT | 9 |
| Horizonte | 9 |
| EPI | 9 |
| Hodgkin | 9 |
| Liver | 9 |
| Hormesis | 9 |
| Hospitals | 9 |
| EM | 9 |
| MOF | 9 |
| MMS | 9 |
| MEE | 9 |
| MBW | 9 |
| Likert | 9 |
| LYG | 9 |
| LLE | 9 |
| Kg | 9 |
| KDT | 9 |
| KA | 9 |
| Intervention | 9 |
| Internal | 9 |
| Integration | 9 |
| Inflammation | 9 |
| Inflammasome | 9 |
| Ignacio | 9 |
| Iceland | 9 |
| IL-1β | 9 |
| IEA | 9 |
| IDUs | 9 |
| IDU | 9 |
| Housing | 9 |
| EN | 9 |
| Ageing | 9 |
| EFS | 9 |
| Ataxia | 9 |
| CARD9del11 | 9 |
| CABG | 9 |
| C2 | 9 |
| Britain | 9 |
| Brief | 9 |
| Biological | 9 |
| Bethesda | 9 |
| Behavior | 9 |
| Bangalore | 9 |
| BFR | 9 |
| Award | 9 |
| Alliance | 9 |
| EA | 9 |
| Agria | 9 |
| Agenda | 9 |
| Maria | 9 |
| AWGS | 9 |
| AVF | 9 |
| AOR | 9 |
| AKI | 9 |
| AHRF | 9 |
| ADH | 9 |
| AA | 9 |
| -5 | 9 |
| CD30 | 9 |
| CDH | 9 |
| COVID19 | 9 |
| Cambridge | 9 |
| E50 | 9 |
| Dysregulation | 9 |
| Dynamics | 9 |
| Di | 9 |
| Detection | 9 |
| Dept | 9 |
| Delphi | 9 |
| Degeneration | 9 |
| Deficiency | 9 |
| DVT | 9 |
| DL | 9 |
| DIC | 9 |
| DDAVP | 9 |
| D3 | 9 |
| Cyclosporine | 9 |
| Comparison | 9 |
| Coalition | 9 |
| Clonal | 9 |
| Class | 9 |
| Chiba | 9 |
| Cardiometabolic | 9 |
| Capacity | 9 |
| Candida | 9 |
| MP | 9 |
| IGF1 | 9 |
| Martin | 9 |
| VCU | 9 |
| analysis | 9 |
| airway | 9 |
| ZAP70 | 9 |
| YF | 9 |
| Xu | 9 |
| Wei | 9 |
| Vol | 9 |
| Veterans | 9 |
| Vaccine | 9 |
| Vaccination | 9 |
| VLBW | 9 |
| VCT | 9 |
| TAC | 9 |
| UVA | 9 |
| USS | 9 |
| UPDRS | 9 |
| UFMG | 9 |
| UEF | 9 |
| UCa | 9 |
| UA | 9 |
| Tronto | 9 |
| Telomere | 9 |
| TUNEL | 9 |
| TNFα | 9 |
| anticardiolipin | 9 |
| appendicular | 9 |
| bp | 9 |
| cmH20 | 9 |
| Medline | 9 |
| μg | 9 |
| δ | 9 |
| ~n | 9 |
| un | 9 |
| th | 9 |
| steroidogenic | 9 |
| scan | 9 |
| sCD80 | 9 |
| rlL-2 | 9 |
| proteinuria | 9 |
| pancytopenia | 9 |
| p=0.005 | 9 |
| p<.05 | 9 |
| nmol | 9 |
| mmHg | 9 |
| methylprednisolone | 9 |
| megalin | 9 |
| kcal | 9 |
| justice | 9 |
| glomerulosclerosis | 9 |
| corticosterone | 9 |
| congress | 9 |
| TET2 | 9 |
| cystinosis | 9 |
| Strength | 9 |
| Podocin | 9 |
| Pathogenesis | 9 |
| PUV | 9 |
| PTDM | 9 |
| PSM | 9 |
| PSL | 9 |
| PR | 9 |
| PONV | 9 |
| PI3K | 9 |
| PGTCS | 9 |
| Organizational | 9 |
| OTKA | 9 |
| OR= | 9 |
| OLT | 9 |
| OCRL1 | 9 |
| Number | 9 |
| Nrf2a | 9 |
| Norway | 9 |
| Nile | 9 |
| Neuroinflammation | 9 |
| NanoString | 9 |
| Mills | 9 |
| Sports | 9 |
| Microbiology | 9 |
| Paulo | 9 |
| OPCA | 9 |
| Populations | 9 |
| SI | 9 |
| Serbia | 9 |
| Sequencing | 9 |
| Prem | 9 |
| Second | 9 |
| Sci | 9 |
| Scarborough | 9 |
| Scales | 9 |
| SSI | 9 |
| SSCP | 9 |
| SNPs | 9 |
| SK | 9 |
| STI | 9 |
| SGS | 9 |
| Redox | 9 |
| R(t | 9 |
| RDA | 9 |
| RGC-32 | 9 |
| RANKL | 9 |
| Random | 9 |
| Rheumatology | 9 |
| S6 | 9 |
| SAH | 9 |
| SCIG | 9 |
| H2.0 | 8 |
| HCoV | 8 |
| HIE | 8 |
| HKU1 | 8 |
| HSCs | 8 |
| Helicobacter | 8 |
| Household | 8 |
| Home | 8 |
| Hopkins | 8 |
| IL-7 | 8 |
| IL-15 | 8 |
| ICT | 8 |
| IIH | 8 |
| Growth | 8 |
| GvHD | 8 |
| GG | 8 |
| Grade | 8 |
| 8 | |
| Golgi | 8 |
| Glasgow | 8 |
| Gilmour | 8 |
| Genetic | 8 |
| Garcia | 8 |
| Gamunex | 8 |
| GR | 8 |
| GL | 8 |
| GD+ | 8 |
| Fälle | 8 |
| Fyn | 8 |
| IL1b | 8 |
| Framingham | 8 |
| IL10 | 8 |
| Louis | 8 |
| IMA | 8 |
| INH | 8 |
| Federal | 8 |
| Mashadi | 8 |
| Malaysia | 8 |
| MMA | 8 |
| MCS | 8 |
| Lp(a | 8 |
| Low | 8 |
| Log | 8 |
| Liao | 8 |
| Level | 8 |
| Leeds | 8 |
| Latino | 8 |
| Lab | 8 |
| LUTD | 8 |
| LE | 8 |
| LC | 8 |
| Jia | 8 |
| JNK | 8 |
| JAK | 8 |
| Ito | 8 |
| Investigation | 8 |
| Interview | 8 |
| Inspire | 8 |
| Indicators | 8 |
| Inc. | 8 |
| IgRT | 8 |
| Ig20Gly | 8 |
| IQ | 8 |
| IPV | 8 |
| Federation | 8 |
| Anstieg | 8 |
| Expert | 8 |
| Carlo | 8 |
| CPR | 8 |
| COX-2 | 8 |
| CHEK2 | 8 |
| CFH | 8 |
| CERAD | 8 |
| CAZ | 8 |
| Box | 8 |
| Biology | 8 |
| Bank | 8 |
| Balance | 8 |
| BUU | 8 |
| BMS | 8 |
| Australian | 8 |
| Asians | 8 |
| Area | 8 |
| Anxiety | 8 |
| Antibody | 8 |
| Alcohol | 8 |
| Al | 8 |
| Advisory | 8 |
| ANG | 8 |
| AL | 8 |
| AKBR | 8 |
| AGL | 8 |
| ABP | 8 |
| = | 8 |
| 3/3-HSD | 8 |
| /d | 8 |
| Meng | 8 |
| CR(t | 8 |
| Casimiro | 8 |
| Exome | 8 |
| Cellular | 8 |
| Eurotransplant | 8 |
| Epilepsy | 8 |
| Economics | 8 |
| ES | 8 |
| EPC | 8 |
| EH | 8 |
| Drosophila | 8 |
| District | 8 |
| Dialysis | 8 |
| Diagnosis | 8 |
| Decision | 8 |
| Dan | 8 |
| DV | 8 |
| DP | 8 |
| DHEA | 8 |
| DEC1 | 8 |
| DBS | 8 |
| Cys | 8 |
| Cyprus | 8 |
| Cushing | 8 |
| Cummins | 8 |
| Cre | 8 |
| Corporation | 8 |
| Core | 8 |
| Coenzyme | 8 |
| Co | 8 |
| Childrens | 8 |
| Charlson | 8 |
| Chan | 8 |
| Medicare | 8 |
| Catalonia | 8 |
| Metallothionein | 8 |
| UI | 8 |
| Wilding | 8 |
| Wallinga | 8 |
| WTCHR | 8 |
| WM | 8 |
| Vincent | 8 |
| Valsiner | 8 |
| Vaccines | 8 |
| VP | 8 |
| VKBR | 8 |
| VHD | 8 |
| Upr | 8 |
| UTA | 8 |
| UP | 8 |
| UN | 8 |
| Tree | 8 |
| Single | 8 |
| Translational | 8 |
| Tool | 8 |
| Thomas | 8 |
| Theory | 8 |
| Th2 | 8 |
| Th1 | 8 |
| Tg | 8 |
| Telangiectasia | 8 |
| Taipei | 8 |
| TTI | 8 |
| TLRs | 8 |
| T2DM | 8 |
| Surinam | 8 |
| Stern | 8 |
| β2MG | 8 |
| William | 8 |
| antigen | 8 |
| control | 8 |
| Microsoft | 8 |
| yo | 8 |
| werden | 8 |
| vasculopathy | 8 |
| umol | 8 |
| tibialis | 8 |
| thrombopenia | 8 |
| therapy | 8 |
| siRNA | 8 |
| pulmonis | 8 |
| prednisolone | 8 |
| pleocytosis | 8 |
| perlecan | 8 |
| p=0.03 | 8 |
| neovascular | 8 |
| nancial | 8 |
| multicentre | 8 |
| mitophagy | 8 |
| mitogens | 8 |
| miR-181 | 8 |
| mean±SD | 8 |
| mayores | 8 |
| mOsm | 8 |
| lg | 8 |
| infliximab | 8 |
| entorhinal | 8 |
| defi | 8 |
| cytometric | 8 |
| cytomegalovirus | 8 |
| St | 8 |
| mid | 8 |
| Sept. | 8 |
| Next | 8 |
| PIK3CD | 8 |
| PFC | 8 |
| PEF | 8 |
| PCV13 | 8 |
| PCT | 8 |
| PCP | 8 |
| PAG | 8 |
| Outbreak | 8 |
| Organisation | 8 |
| Ophthalmology | 8 |
| OSOM | 8 |
| OPG | 8 |
| OMS | 8 |
| OECD | 8 |
| NOS | 8 |
| PLV | 8 |
| NOD2 | 8 |
| NIA | 8 |
| NGOs | 8 |
| NCRCGD | 8 |
| Müller | 8 |
| Motor | 8 |
| Mother | 8 |
| Monte | 8 |
| Monitoring | 8 |
| Monitor | 8 |
| Moloney | 8 |
| Mobility | 8 |
| Mid | 8 |
| Sclerosis | 8 |
| PKC | 8 |
| NFkB | 8 |
| PT | 8 |
| Reactive | 8 |
| Scheme | 8 |
| Parkin | 8 |
| Schaie | 8 |
| Sch | 8 |
| SWS | 8 |
| SNLI | 8 |
| SMA2 | 8 |
| SIHI | 8 |
| SHC | 8 |
| S2 | 8 |
| Rx | 8 |
| Rome | 8 |
| Rev | 8 |
| Resident | 8 |
| SIRS | 8 |
| Rauvola | 8 |
| Q4 | 8 |
| Pilot | 8 |
| PepTivator | 8 |
| RTA | 8 |
| Preferred | 8 |
| Programs | 8 |
| Q1 | 8 |
| Puerto | 8 |
| QoL | 8 |
| R2 | 8 |
| RCPCH | 8 |
| RH | 8 |
| RM | 8 |
| IGIV | 7 |
| Immunity | 7 |
| IDDM | 7 |
| IL-1ra | 7 |
| IMV | 7 |
| IPC | 7 |
| Hôpital | 7 |
| ITB | 7 |
| IgAGA | 7 |
| IgD | 7 |
| Inhibitors | 7 |
| Immunogenicity | 7 |
| Indonesia | 7 |
| Ingelhardt | 7 |
| Inhibition | 7 |
| Institutional | 7 |
| Inutest | 7 |
| Items | 7 |
| Huang | 7 |
| Jamar | 7 |
| Jacobs | 7 |
| Hz | 7 |
| HBoV1 | 7 |
| Hpa | 7 |
| HHS | 7 |
| Good | 7 |
| Joubert | 7 |
| Gross | 7 |
| Grühn | 7 |
| Guidelines | 7 |
| Guo | 7 |
| Gupta | 7 |
| HAE | 7 |
| HDRS | 7 |
| HI | 7 |
| Host | 7 |
| HKD | 7 |
| HRQOL | 7 |
| HSPN | 7 |
| Hallmarks | 7 |
| HbA1c | 7 |
| Head | 7 |
| Helsinki | 7 |
| Hgb | 7 |
| Ho | 7 |
| Johnson | 7 |
| MTB | 7 |
| KLOTHO | 7 |
| MZR | 7 |
| MEDLINE | 7 |
| MEH | 7 |
| MHS | 7 |
| MKS | 7 |
| MND | 7 |
| MQ | 7 |
| MTD | 7 |
| MUF | 7 |
| MYCBP2 | 7 |
| Maret | 7 |
| MARINA | 7 |
| Matrix | 7 |
| Mayer | 7 |
| Media | 7 |
| Mei | 7 |
| Melbourne | 7 |
| Memory | 7 |
| Merla | 7 |
| Ming | 7 |
| German | 7 |
| MCSF | 7 |
| MAG3 | 7 |
| Kampala | 7 |
| Lazio | 7 |
| Kotter | 7 |
| Kruskal | 7 |
| LFG | 7 |
| LI | 7 |
| LPL | 7 |
| LSA | 7 |
| LVEDD | 7 |
| Lactobacillus | 7 |
| Lavinder | 7 |
| Leila | 7 |
| MAG | 7 |
| Lewis | 7 |
| Liang | 7 |
| License | 7 |
| Local | 7 |
| Lombardy | 7 |
| Lord | 7 |
| Loss | 7 |
| Lu | 7 |
| M235 | 7 |
| Goals | 7 |
| Beth | 7 |
| Geographic | 7 |
| CFU | 7 |
| Belfast | 7 |
| Bellingtier | 7 |
| Berlin | 7 |
| Mn | 7 |
| Blue | 7 |
| Brown | 7 |
| Byblos | 7 |
| CAVH | 7 |
| CBR | 7 |
| CMR | 7 |
| Baby | 7 |
| CMT | 7 |
| COG4 | 7 |
| COL | 7 |
| COL4A3 | 7 |
| COL4A4 | 7 |
| CPD | 7 |
| CSAD | 7 |
| CUP | 7 |
| CVVHD | 7 |
| Baseline | 7 |
| BREF | 7 |
| Gender | 7 |
| AT+RT | 7 |
| -2 | 7 |
| A&E | 7 |
| AASI | 7 |
| ADM | 7 |
| AES | 7 |
| AHC | 7 |
| AICDA | 7 |
| ALN | 7 |
| ASES | 7 |
| Adagen | 7 |
| BPSA | 7 |
| Administration | 7 |
| Alpha | 7 |
| Alu | 7 |
| Assistance | 7 |
| Associations | 7 |
| BCC | 7 |
| BEN | 7 |
| BFB | 7 |
| BOTOX | 7 |
| Cells | 7 |
| Chang | 7 |
| Chlamydia | 7 |
| FRNS | 7 |
| EYA1 | 7 |
| Early | 7 |
| Easterlin | 7 |
| Enterococcus | 7 |
| Excellence | 7 |
| FG | 7 |
| FL | 7 |
| FNIH | 7 |
| FR | 7 |
| FSE | 7 |
| Choi | 7 |
| Fever | 7 |
| Florida | 7 |
| Free | 7 |
| GCS | 7 |
| GOSH | 7 |
| Gait | 7 |
| Gallup | 7 |
| Gamma | 7 |
| Gauteng | 7 |
| EWGSOP-2 | 7 |
| ESRF | 7 |
| EMBASE | 7 |
| EEF | 7 |
| ConA | 7 |
| Conclusion | 7 |
| Conference | 7 |
| Contact | 7 |
| Cyclophosphamide | 7 |
| DELOS | 7 |
| DGS | 7 |
| DT | 7 |
| Dickinson | 7 |
| Disorder | 7 |
| Disorders | 7 |
| Distress | 7 |
| Dp71 | 7 |
| Duke | 7 |
| Dystonia | 7 |
| E60 | 7 |
| EARSS | 7 |
| ECLS | 7 |
| EDTA | 7 |
| Mixup | 7 |
| IL-5 | 7 |
| Monocyte | 7 |
| TL | 7 |
| YPLL | 7 |
| Year | 7 |
| Zhao | 7 |
| abatacept | 7 |
| agrin | 7 |
| atherogenesis | 7 |
| auf | 7 |
| bevacizumab | 7 |
| bisphosphonate | 7 |
| bronchoalveolar | 7 |
| cDNA | 7 |
| cGMP | 7 |
| cepacia | 7 |
| confi | 7 |
| corticotropin | 7 |
| ct | 7 |
| cytopenias | 7 |
| d. | 7 |
| dDAVP | 7 |
| da | 7 |
| deaminase | 7 |
| Wide | 7 |
| Welle | 7 |
| Wellbeing | 7 |
| Users | 7 |
| TMA | 7 |
| TOR | 7 |
| Takayasu | 7 |
| Tinetti | 7 |
| Trends | 7 |
| U. | 7 |
| UPRT | 7 |
| Univariate | 7 |
| Universitario | 7 |
| VE | 7 |
| Welfare | 7 |
| VSD | 7 |
| VSTs | 7 |
| Venezuela | 7 |
| WA | 7 |
| WMLA | 7 |
| WVS | 7 |
| Wahl | 7 |
| Wallis | 7 |
| Wegener | 7 |
| di | 7 |
| du | 7 |
| ea | 7 |
| t;g | 7 |
| ramipril | 7 |
| rotaviruses | 7 |
| selectin | 7 |
| series | 7 |
| simplex | 7 |
| subcapsular | 7 |
| syndrome | 7 |
| t(228 | 7 |
| t2 | 7 |
| tas | 7 |
| prefrail | 7 |
| tion | 7 |
| tocilizumab | 7 |
| tx | 7 |
| uL | 7 |
| yrs | 7 |
| ~d | 7 |
| ~f | 7 |
| ~nd | 7 |
| Moya | 7 |
| protein-1 | 7 |
| pre | 7 |
| east | 7 |
| lacunar | 7 |
| enalapril | 7 |
| hr | 7 |
| ht | 7 |
| i.v | 7 |
| iLVM | 7 |
| injectate | 7 |
| iv | 7 |
| kappa | 7 |
| kappaB | 7 |
| lo | 7 |
| pCO2 | 7 |
| membranoproliferative | 7 |
| miR-34a | 7 |
| monogenic | 7 |
| n=15 | 7 |
| n=16 | 7 |
| n=21 | 7 |
| ned | 7 |
| non | 7 |
| p=0.07 | 7 |
| TLR7 | 7 |
| más | 7 |
| TISS | 7 |
| Patricia | 7 |
| PEEP | 7 |
| PIAP | 7 |
| PLAID | 7 |
| PN | 7 |
| PNP | 7 |
| PRIMS | 7 |
| PSV | 7 |
| Paediatrics | 7 |
| Papanicolau | 7 |
| Pediatr | 7 |
| Oncology | 7 |
| Peng | 7 |
| Perceived | 7 |
| Personal | 7 |
| Pn | 7 |
| Potential | 7 |
| Prasad | 7 |
| Prediction | 7 |
| Prime | 7 |
| Princess | 7 |
| PBMC | 7 |
| Olsson | 7 |
| Quantitative | 7 |